DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
BEN - 1 Janssen - 1 Christoph Ruedig - 1 Maya Zlatanova - 1 Europe hasn't - 1 Matt Wilson - 1 Wilson - 1 Christoph Massner - 1
Top related locs:
Europe New York American
Top related orgs:
Big Pharma - 1 pharma - 1 Janssen Pharmaceuticals - 1 Tempus - 1 Venture - 1 Albion VC - 1 US - 1 Earlybird Ventures - 1

Search resuls for: "Christoph Ruedig"


2 mentions found


☆ Clinical data is a goldmine — but Europe's startups are struggling to grow
  + stars: | 2023-08-14 | by ( Riddhi Kanetkar | ) www.businessinsider.com   time to read: +5 min
Big Pharma and biotech companies often outsource clinical trials to external companies. Europe's early-stage clinical trials startups are flush with funds but they're struggling to grow. The fate — and market cap — of a biotech company often lies with a successful clinical trial. The COVID-19 pandemic also spotlighted another promising alternative to carry out these trials — startups. While the US touts around a dozen clinical trials unicorns valued at $1 billion or higher, per Dealroom estimates, Europe's startups are lagging behind.
Persons: BEN, Janssen, Christoph Ruedig, Maya Zlatanova, Europe hasn't, Matt Wilson, Wilson, Christoph Massner, it's, Ruedig Organizations: Big Pharma, pharma, Janssen Pharmaceuticals, Tempus, Venture, Albion VC, US, Earlybird Ventures Locations: Europe, New York, American
☆ Over 150,000 tech workers have lost their jobs in 2022 with education, health, and crypto sectors among the worst affected
  + stars: | 2022-12-15 | by ( Riddhi Kanetkar | ) www.businessinsider.com   time to read: +4 min
Over 150,000 tech workers have lost their jobs in 2022, according to tracker site Layoffs.fyi. More than 150,000 tech workers have lost their jobs this year, according to data from tracker site Layoffs.fyi. Industries that grew rapidly during the pandemic — such as health tech, education tech, and crypto — have been the worst affected in 2022. The issue, he said, was that some investors in crypto, education tech, and health tech paid little heed to economic fundamentals. Amid recessions, B2B sub-sectors such as corporate education tech and employee coaching remain promising pockets within education tech, the investor added.
0 next >>
Total: 2